Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (4): 806-811    DOI: 10.31083/j.ceog4804129
Systematic Review Previous articles | Next articles
Efficacy of tamoxifen for infertile women with thin endometrium undergoing frozen embryo transfer: a meta-analysis
Zhongying Huang1, 2, †, Zhun Xiao1, 2, †, Qianhong Ma1, 2, Yu Bai1, 2, Feilang Li3, *()
1Department of Obstetrics and Gynecology, Second University Hospital, Sichuan University, 610041 Chengdu, Sichuan, China
2Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, 610041 Chengdu, Sichuan, China
3Department of Obstetrics and Gynecology, West China Guang-an Hospital, Sichuan University, 638001 Guangan, Sichuan, China
Download:  PDF(542KB)  ( 76 ) Full text   ( 13 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Background: This study aims to compare the effect of tamoxifen (TMX) vs. other regimens on endometrial thickness (EMT), clinical pregnancy, implantation, miscarriage, and live birth rates in women with thin endometrium undergoing frozen-thawed embryo transfer (FET). Methods: We searched the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, and CINAHL from inception to November 2020 and cross-checked the references of relevant articles. We included randomized controlled trials (RCTs) and nonrandomized controlled trials (non-RCTs) to compare TMX with other regimens for endometrium preparation in women with thin endometrium undergoing FET. We pooled weighted mean differences (WMD) with 95% confidence intervals (CI) for continuous variables (EMT) and odds ratios (OR) with 95% CI for binary variables (i.e., clinical pregnancy rate, implantation rate, and first trimester miscarriage rate). Results: An RCT and three controlled trials (2 before-after and 1 retrospective controlled trials) were included in the final review. One study including 154 women and comparing TMX-FET with natural cycle (NC)—FET showed a significant increase in EMT in the TMX cycle (7.87 ± 1.48 mm vs. 6.11 ± 0.98 mm, P < 0.05). Three studies compared the EMT in the TMX and the hormone replacement treatment (HRT) cycles. The pooled analysis showed beneficial effect of TMX on EMT (WMD = 2.06, 95% CI = 1.86–2.27, P < 0.00001). An RCT and a retrospective controlled trial compared TMX and ovulation induction (OI) with Letrozole/human menopause gonadotropin (hMG) for endometrium preparation in women with thin endometrium undergoing FET. No significant difference in clinical pregnancy rates (OR = 1.03, 95% CI = 0.71–1.51), implantation rate (OR = 1.03, 95% CI = 0.76–1.38), or miscarriage rate (OR = 0.91, 95% CI = 0.40–2.06) was observed. No significant difference in EMT was found between TMX and OI with Letrozole/hMG in the included studies. Conclusions: In women with thin endometrium undergoing FET, the use of TMX may result in improved EMT than other regimens. At present, evidence supporting the preferred use of TMX over other regimens as clinical pregnancy rate, implantation rate, or the first trimester miscarriage rate is insufficient.
Key words:  Tamoxifen      Thin endometrium      Frozen embryo transfer      Meta-analysis     
Submitted:  06 March 2021      Revised:  21 March 2021      Accepted:  01 April 2021      Published:  15 August 2021     
Fund: 
81200453/National Natural Science Foundation of China
*Corresponding Author(s):  Feilang Li     E-mail:  fll_guangan@sina.com
About author:  These authors contributed equally.

Cite this article: 

Zhongying Huang, Zhun Xiao, Qianhong Ma, Yu Bai, Feilang Li. Efficacy of tamoxifen for infertile women with thin endometrium undergoing frozen embryo transfer: a meta-analysis. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 806-811.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog4804129     OR     https://ceog.imrpress.com/EN/Y2021/V48/I4/806

[1] Zhu Chen, Hui Huang, Jingcen Hu, Shuyu Wang, Liang Xia. Circulating neutrophil gelatinase-associated lipocalin and gestational diabetes mellitus: a meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1206-1214.
[2] Arzu Yurci, Aret Kamar, Nurettin Turktekin, Ramazan Ozyurt. Comparison of immediate versus delayed frozen embryo transfer on reproductive outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 263-269.
[3] Shi-Fu Hu, Ying-Ying Wang, Yan-Qing Wu, Qiong Yu. Timing of prophylactic antibiotic use during elective caesarean section: a meta-analysis of randomised controlled trials[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 31-36.
[4] Y. Sun, X. Chen, X. Yuan, L. Xu, Y.C. Jin, T.H. Ji, X.L. Wang, H.H. Dai, W.J. Cheng. Levonorgestrel intrauterine system versus oral progestin for preventing the recurrence of endometrial polyps after hysteroscopic resection: A meta-analysis of 19 randomized controlled trials[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 821-828.
[5] Sh. Gaafar, T. Hanafy, S. El Morshedy, H. Mansour. Effect of extended embryo culture after thawing on clinical pregnancy rate[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 764-768.
[6] J. Dun, X. Wang, J. Yang, J. Xu. Clinical practice guidelines on polycystic ovary syndrome: a systematic review and comparative meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 465-471.
[7] J. Chollet, L. A. Meyn, F. Mermelstein. Weekly vaginal administration of tamoxifen for three months in postmenopausal women with vulvar and vaginal atrophy: a possible new treatment approach?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 285-288.
[8] Y. Zheng, G. Niu, H. Zhang, W. Lu, Z. Liu. Estrogen replacement therapy is not a recommended therapy for postmenopausal women with coronary heart disease: a meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 219-226.
[9] Jianping Zhang, Fang Yang, Yaoqin Wang, Yonglian Wang, Hongmei Liang, Xueqing Wu. Effect of differential endometrial injury timing on frozen-thawed embryo transfer pregnancy outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 118-122.
[10] U. Indraccolo, R. Ventrone, G. Scutiero, P. Greco, S.R. Indraccolo. Interventions for treating amniotic fluid embolism: a systematic review with meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 666-677.
[11] J. H. Check, R. Cohen. A second successful pregnancy using oocytes from a woman with premature ovarian failure with embryos transferred to a gestational carrier[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 507-508.
[12] J.H. Check. A second case of successful conception in a natural cycle despite a maximum endometrial thickness in the follicular phase of four mm[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 341-342.
[13] K. J. Lim, D. Y. Yoon, J. H. Kim, Y. K. Cho, H. J. Kim, H. S. Ahn, I. M. Ahn. Percutaneous radiofrequency ablation for symptomatic uterine leiomyomas: a systematic review and meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(5): 643-649.
[14] D. Summers, J. H. Check, J. K. Choe. A prospective comparison of outcome following cryopreservation using vitrification vs. a modified slow-freeze protocol of 2 pronuclear (2PN) and day 3 multi-cell embryos[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(3): 330-331.
[15] C. M. Wang, S. L. Zhang. Non-association of MMP-9 -1562C/T polymorphism with preeclampsia risk: evidence from a meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(6): 730-735.
No Suggested Reading articles found!